Congratulations to Moving Analytics & HeartHero

The American College of Cardiology’s Scientific Session is an annual event that draws physicians, vendors, startups, and subject matter experts from across the United States. For the past two years, AngelMD has had the privilege of hosting the ACC’s Innovation Challenge. The Innovation Challenge pits a pool of startup contestants against one another in a Shark Tank-style pitch competition, where the teams compete for a pool of prizes.

This year’s competition was broken into two categories: Artificial Intelligence, and Digitally-Enabled Medical Devices. Given AI’s rise of importance in healthcare, the ACC wanted to give companies who make heavy use of AI the opportunity to showcase what they have accomplished, and what they’re planning for the future. The teams that were chosen to compete came from the AngelMD network, and were scored not only by AngelMD but also by member-physicians of the ACC.

The Finalists

Artificial Intelligence

  • Care Angel
  • HealthPals
  • Moving Analytics
  • RecoverLINK

Medical Devices

  • GraftWorx
  • Sira Medical
  • cliexa
  • HeartHero

The Winners

Moving Analytics was chosen as the winner from the Artificial Intelligence category. Their pitch showed a strong understanding of the market, its challenges, and a viable way toward solving them.

For heart disease patients, cardiac rehabilitation is a proven method of preventing readmission. Unfortunately, a lack of convenient options for patients means that a mere 15 percent of them ever complete CR programs. Moving Analytics helps hospitals implement virtual CR and secondary prevention programs for cardiac patients. In a value-based care world, where readmission can lead to stiff penalties, it’s critical that patients have access to care that it not only effective, but also considerate of their constraints.

HeartHero was chosen as the winner from the Medical Device category. The company pitched its ultra-portable, affordable, user-friendly AED to the crowd at the ACC.19 Innovation Challenge. A product that can readily save lives, and is available at a lower cost than the status quo was obviously a big hit with the audience.

The use of an AED at the time of an SCA event significantly increases the chance of survival, but currently, AEDs are only used in a small fraction of cases of out-of-hospital SCAs. This gap exists because 70% of out-of-hospital SCA events occur at home, but AEDs are only currently readily available to businesses and institutions. The HeartHero team sees an incredible opportunity to bridge this gap and create a consumer-friendly solution to address these in-home SCA events.


Our congratulations to both teams for their performance, and for winning the Innovation Challenge. Be on the lookout for a full-length article, featuring both companies, that will appear in an upcoming issue of ACC’s Cardiology magazine.

Continue reading

Announcing the ACC19 Innovation Challenge Finalists

AngelMD is joining forces with the American College of Cardiology to bring you the ACC19 Innovation Challenge, as part of the ACC.19 Annual Scientific Sessions in New Orleans, Louisiana. This year, the focus is on Artificial Intelligence and Digitally-Enabled Medical Devices. We will be doing a deep dive into each of the winning companies, to be published in ACC’s Cardiology magazine.

On top of being featured in Cardiology, each winner will also receive the following:

  • A $5,000 credit toward a structured investment syndicate through AngelMD
  • A commemorative plaque presented by the ACC
  • Complimentary turnkey kiosk space at the ACC.20 Future Hub
  • Complimentary exhibit space at the ACC.20 Expo

Artificial intelligence (and relatedly, machine learning) is a hotbed topic for healthcare right now. With major medical names entering the ring, as well as companies like Apple and Amazon, AI is primed to be the topic to watch in the years to come. Here are the finalists for the ACC.19 Innovation Challenge:

Likewise, digitally-enabled medical devices are seeing some of the highest levels of investment activity. We’ve finally moved well-beyond smart watches and into a world where conditions such as hemodialysis and sudden cardiac arrest can be more closely monitored and treated through medical devices. These are the finalists from the Digitally-Enabled Medical Device category.

Join us for the ACC.19 Innovation Challenge, March 17th and 18th at the ACC’s 68th annual expo. Can’t make it to the expo? Be sure to follow AngelMD on Facebook where we will be announcing the winners as the event happens.

Continue reading

Introducing the ACC.19 Innovation Challenge

Returning for its second year, the American College of Cardiology will partner with AngelMD to host the popular ACC.19 Innovation Challenge. Entrepreneurs and innovators will pitch their ideas in two categories that support cardiology. The ACC.19 Innovation Challenge is being hosted at the Future Hub Learning Destination (Expo Hall, #146) at the ACC.19 Annual Scientific Sessions in New Orleans, LA on March 17 & 18, 2019.

Your AngelMD startup profile is your application, so make sure that it is up to date. The deadline for profile updates is January 15th, 2019. 

The Categories

Artificial Intelligence Solutions – Artificial intelligence (AI) in healthcare is the use of algorithms and software to approximate human cognition in the analysis of complex medical data. The primary aim of health-related AI applications is to analyze relationships between prevention or treatment techniques and patient outcomes. Does your innovation have the ability to gain information, process it and give a well-defined output to improve the practice of cardiology? Apply to pitch

Digitally-Enabled Medical Devices – Utilizing digital technology to enhance your medical device innovation, providing valuable data that can be used to improves efficiency, care and outcomes. Is your medical device for cardiology enabled with digital technology? Register today.

Continue reading

AngelMD and ACEP Announce Winners from the ACEP18 Innovation Challenge

There is likely no one place more impacted by innovation than the emergency room. That’s part of the reason why AngelMD is proud to be in association with the American College of Emergency Physicians. A field of over 60 healthcare startups in emergency medicine applied to participate in the ACEP18 innovatED Innovation Challenge. Through an evaluation process completed by 50 emergency physician members of AngelMD, the top 4 innovations in medical device and top 4 innovations in digital health were selected to participate in pitch competitions in the innovatED exhibit space at ACEP18. Additional startups were allowed to exhibit in the space as well.

The presenters, determined by emergency physicians from ACEP and AngelMD:

Digital Health Category: DiA Imaging Analysis, inContext Reporting, navigatER, UBQ

Medical Device Category: CoLabs, HeartHero, Kestrel Labs, Linear Health Sciences

The exhibitors, determined by emergency physicians from ACEP and AngelMD:

Digital Health Category: HealthPals, Through the Cords, Output Medical

Medical Device Category: Aeronyde, Clinivantage, Format Health

After all of the pitches were complete, a panel of four emergency medicine experts deliberated on the winner. Attendees of the Innovation Challenge, as well as well as those watching the live stream through AngelMD also cast their vote for their top innovation. With the audience favorite counting as the fifth judge, over 350 participants cast their votes for winners from the Digital Health and Medical Device categories.

UBQ was chosen as the winner for Digital Health. The company specializes in helping emergency departments increase revenues, decrease cost, and improve the care experience for both patients and staff. UBQ’s Resource Prediction Machine uses artificial intelligence to predict the severity of patient illness on arrival. This helps provide for better triage, more efficient queues, and treatment clarity.

In the Medical Device category, HeartHero was chosen as the winner. HeartHero is focused on changing the dismal outcome of sudden cardiac arrest. The company has developed a smaller, lighter AED than any that is currently on the market. The device is powered by a standard 9-volt battery, and is perfect for use in any at-risk household.

Each winning company received a prize package that includes a $5,000 credit toward investment syndication services through AngelMD. These services include investor accreditation verification, the creation of a special purpose vehicle for angel investors, stock issue documents, the collection of digital signatures, collection of funds, and escrow service for the investment syndicate.

The two companies will be invited back to ACEP’s 2019 conference in Denver, where they will be provided with a booth space valued at over $3,000.

Continue reading

Join AngelMD at the IGNITE Fire Pitch Competition

AngelMD is proud to be a part of the Annual Greater Houston Women’s Chamber/IGNITE Fire Pitch Competition. It will be held October 25th at TMCx and we don’t want you to be left out. The Competition showcases innovative, women-led tech startups focused on solving some of the most challenging problems in healthcare. Eight finalists have been selected from a pool of accomplished applicants from across the globe. They have been vetted and coached by industry experts in preparation to pitch to an audience of potential customers, potential investors, and interested parties while competing for prizes awarded by presenting sponsors TMCx and JLabs. This year, AngelMD’s Dr. Wendy Whittington joins the team of advisors. The invitation and registration provide more specific details about the event.

Adrianna Cantu, CEO of Austin based Reveallix was last year’s winner. She was awarded admission to the TMCx Digital Health Accelerator Program which she successfully completed this past June as well as a $15,000 Convertible Note. Revealix has amassed a rich and deep network of medical, scientific, regulatory, and reimbursement experts who are actively engaged in efforts to successfully bring their digital health solution to market. Through the ongoing engagement with Adrianna’s 2017 Fire Pitch Coach, Terri Burke, these connections extend beyond Texas and into Silicon Valley. Revealix is now positioned to attain the next critical milestone on the company’s roadmap, developing their Diabetic Limb Surveillance solution to enter the market in 2019. Adrianna is readying the company for their initial raise of seed capital in Q4 2018. The Fire Pitch Competition played a key role in accelerating her company’s growth.

With your support, the GHWCC can make Houston a leader in identifying, investing, and growing successful women led startups. Sponsorship details can be found at the Ignite section of the GHWCC website.

Continue reading